You are here:
NZLII >>
Databases >>
New Zealand Bill of Rights Act Reports >>
2020 >>
[2020] NZBORARp 6
Database Search
| Name Search
| Recent Documents
| Noteup
| LawCite
| Download
| Help
Smokefree Environments and Regulated Products (Vaping) Amendment Bill (Inconsistent) (Section 14) [2020] NZBORARp 6 (26 February 2020)
Last Updated: 11 March 2020
Report of the
ATTORNEY-GENERAL
under the New Zealand Bill of Rights Act
1990
on the Smokefree Environments and
Regulated Products (Vaping)
Amendment Bill
Presented to the House of Representatives pursuant to Section 7 of the New
Zealand Bill of Rights Act 1990 and Standing Order 265
of the Standing Orders of
the House of Representatives
1
- I
have considered whether the Smokefree Environments and Regulated
Products
(Vaping) Amendment Bill (`the Bill') is consistent with the rights
and freedoms affirmed in the New Zealand Bill of Rights Act 1990
(`the Bill of
Rights Act'). I have concluded that the provisions of the Bill prohibiting the
advertising, promotion, or sponsorship
of vaping products and smokeless tobacco
devices (the provisions in Part 2, subparts 1 and 2) are inconsistent with the
right to
freedom of expression affirmed in s 14 of the Bill of Rights Act.
- As
required by s 7 of the Bill of Rights Act and Standing Order 265, I draw this to
the
attention of the House of Representatives.
The Bill
- The
Bill amends the Smoke-free Environments Act 1990 (`the Act') to regulate
vaping
liquid (with and without nicotine), devices and components, and
smokeless tobacco devices (the tobacco component is already regulated).
- The
Bill extends many of the existing provisions of the Act to vaping products
and
smokeless tobacco devices including:
4.1 prohibiting the
sale, and supply in a public place, of vaping products and
smokeless tobacco devices to people under the age of 18 years;
4.2 prohibiting advertising, promotion and sponsorship of vaping products
and
smokeless tobacco devices;
4.3 prohibiting inducements and rewards associated with vaping products
and
smokeless tobacco devices (e.g. discounts and loyalty points); and
4.4 prohibiting vaping and the use of similar tobacco devices in legislated
smoke-
free areas including indoor workplaces, early childhood centres, and schools,
as well as, subject to passage of the Smoke-free Environments
(prohibiting
Smoking in Motor Vehicles Carrying Children) Bill, vehicles carrying children
under the age of 18 years.
- The
Bill enables the Director-General of Health to approve a vaping retailer as
a
`specialist vape retailer'. The Bill makes some distinctions within the
regulatory framework between a specialist vape retailer and
a (generic)
retailer.
- Certain
provisions are specifically designed to reduce the appeal of vaping
and
smokeless tobacco products to young persons and non-smokers, including
the creation of regulations restricting the permitted flavours
and colours of
the substances used by these products.
- The
Bill also contains provisions aimed at monitoring and improving the safety
of
vaping and smokeless tobacco products. It introduces a new notification
regime for manufacturers and importers of these products,
including obligations
to provide the details of their product to a product database and to provide
notice of any adverse reactions
they become aware of. Retailers must not sell
products which are not compliant with this
regime.
WELLINGTON, NEW ZEALAND
Published by Order of the House of Representatives - 2020
- In
New Zealand, nicotine e-cigarettes were believed to be unlawful under the Act
until
the judgment in Philip Morris v Ministry of Health [2018] NZDC 4478,
which found that the Act's prohibition on tobacco products used for chewing
or 'any other oral use' extended only to products used
in a way similar to
chewing and not to heated smokeless tobacco products. Since then, there has been
a rapid growth in vape stores
and the availability of e-cigarettes in generic
stores (supermarkets, dairies, service stations) and mass and social media
advertising.
- The
Bill is designed to bring vapes and heated tobacco products within essentially
the
same set of regulations and restrictions as traditional tobacco products,
subject to some tailored exceptions. The policy position
underpinning the Bill
recognises that vaping can be a legitimate and useful way of assisting smokers
to cease tobacco use but seeks
to prevent its uptake as a new habit by
non-smokers.
The evidence of harm
- An
important issue underlying my advice on this Bill is the lack of available
evidence
for harm associated with vaping. The Regulatory Impact Statement
(`RIS') accompanying the Bill notes the lack of conclusive evidence
on the
benefits or harm of vaping products,
stating:1
"There are limitations on the
extent to which the problem can be accurately defined and the impacts of the
proposals assessed and
quantified. This reflects a lack of information on the
long-term effects of vaping and using many types of smokeless tobacco product,
as well as the local market."
- The
RIS goes on to explain the scientific consensus that vaping is "significantly
(around
95 percent) less harmful than smoking".2
These improvements in physical safety arise from a lack of combustion and the
limiting of toxicants, where present at all, to levels
considered a negligible
risk to health. While the long-term effects of vaping will reportedly not be
known for many years, and long-term
exposure may be associated with increased
health risks, "the magnitude of such risks is likely to be substantially lower
than those
of smoking, and extremely low in absolute
terms".3 While vaping products do contain nicotine, the
RIS advises that there is evidence that use of small quantities of nicotine is
associated
with few risks, and the addiction potential of nicotine in vaping
products appears to be low, at least with current technology.
- The
RIS records that New Zealand has seen a rapid increase in vaping over recent
years,
including among young people. One survey found that 27.7 percent of
14-15 year olds had tried vaping in 2016, compared to 7.1 percent
in
2012.4 Rates are higher among young Maori, 45.8 percent
of whom had tried vaping in 2016, compared with 22.2 percent of non-Maori. As
young
adulthood represents a vulnerable time for the initiation, development and
establishment of smoking behaviours, there is a concern
I Regulatory
Impact Statement: Support smokers to switch to alternatives (Ministry of Health,
January 2019) at page 3.
2 At page
10.
3 At page 11.
The Youth Insights Survey 2016,
cited at page 10 of the RIS.
that the uptake of vaping will result in the establishment of smoking
behaviour in some young people.
- However,
while recognising the broad concern by commentators that experimentation
by
young people may lead to regular vaping and/or smoking, the RIS indicates that
the few studies on this topic to-date are inconclusive
on the existence of such
a 'gateway' effect.' Some reviews have found a link between persons 'ever
vaping' and 'ever smoking at a
later point in time' but acknowledge that it
cannot be concluded that the former causes the latter. Another study has
concluded against
such a relationship, as smoking has continued to decline while
vaping uptake has increased. The RIS concludes, in relation to concerns
that
young people who do not smoke may become regular vapers, that "[t]here is, to
date, no robust evidence to support this
concern".6
- The
Ministry of Health advises that there has been a rapid increase in vaping rates
in
the United States, and similar trends may also be appearing in Canada. It
advises that a variety of approaches have been taken, or
are being considered,
in overseas jurisdictions to control the uptake in vaping. Although useful
context, this information does not
displace the conclusions in the RIS that
there is currently no conclusive evidence of any harm or gateway effect
associated with
vaping.
Section 14 of the Bill of Rights Act
(freedom of expression)
- Section
14 of the Bill of Rights Act affirms that everyone has the right to freedom
of
expression, including the freedom to seek, receive, and impart information
and opinions of any kind in any form. The right to freedom
of expression extends
to all forms of communication which attempt to express an idea or meaning,
including commercial speech such
as advertising.
- A
number of clauses in the Bill contain provisions that engage the right to
freedom of
expression. These include:
16.1 the prohibition of
advertising of regulated products, subject to certain limited
exceptions (Part 2, subpart 1);
16.2 restrictions on the use of trademarks and company names, including
parts of
company names, related to the sale of regulated products (Part 2, subpart 2);
and
16.3 a requirement for standardised packaging on regulated products, as well
as
health messages and other information required by regulations (Part 3).
- The
above provisions in the Bill limit freedom of expression in a number of
ways.
Advertisements, notices, packaging and other communications to
customers are forms of expression, and prohibition or regulation of
their
content engages section 14 of the Bill of Rights
Act.
5 At page 10.
6 At page 2.
18. The focus of my concern with this Bill is whether the extensive
restrictions on the
advertising of regulated products (contained in Part 1, subparts 1 and 2) are
justifiable under the Bill of Rights Act, given the
limitations on the evidence
of harm identified above.
19. For the avoidance of doubt, I note that the provisions of the Bill which
limit the flavours
and colours that can be included in a vaping substance (Part 4) are a
balanced and proportionate approach to regulation.
Are the limitations justified and proportionate under s 5 of the Bill of
Rights Act?
20. Where a provision appears to limit a particular right or freedom, it may
nevertheless be
consistent with the Bill of Rights Act if it can be considered a reasonable
limit that is demonstrably justified in a free and democratic
society under s 5
of the Bill of Rights Act. The s 5 inquiry may be approached as
follows:7
- does
the provision serve an objective sufficiently important to justify some
limitation of the right or freedom?
- if
so, then:
is the limit rationally connected with the objective?
- does
the limit impair the right or freedom no more than is reasonably necessary for
sufficient achievement of the objective?
- is
the limit in due proportion to the importance of the objective? Is the
objective sufficiently important?
21. The proposal for the Bill
"seeks to strike a balance between the objectives of supporting
smokers to switch to significantly less harmful products and protecting
children and young people from any risks associated with an
increased
availability of vaping and smokeless tobacco
products".8 The Bill amends the purposes of the Act to
refer to vaping, with new purposes including: "to prevent the normalisation of
vaping",
"to regulate the safety of vaping products and smokeless tobacco
products" and "to regulate and control the marketing, advertising
and promotion
of regulated products [...] in order to improve public health by— [...]
(ii) discouraging non-smokers, especially
children and young people, from vaping
or using smokeless tobacco products".9
22. The Bill therefore seeks to achieve several objectives. In respect of
the provisions
prohibiting advertising and marketing, the objective of the Bill is to
protect the health of the public, particularly young persons,
from the potential
ill effects of vaping and smokeless tobacco products.
7 Hansen v R [2007] NZSC 7 at
[123].
8 RIS, above nl, page
1.
9 At clause 6, replacing section 3A of the
Act.
- The
protection of public health is an important objective, especially in regard
to
vulnerable groups such as children. In the abstract, such an objective can
justify limitations on rights protected under the Bill
of Rights Act. However,
the importance of such an objective in context will be contingent on the
evidence supporting the legitimate
risk of harm which the public requires
protection from. I address this issue in further detail below, in relation to
the assessment
of proportionality.
- I
accordingly consider that the objective underlying these provisions is
sufficiently
important to justify some limits on the rights protected in the
Bill of Rights Act.
Is there a rational connection between the
limit and the objective?
- Some
deference may be appropriate in assessing the requirement of rational
connection,
particularly for complex social policy
issues.10 There can be 'many ways to approach a
particular problem, and no certainty as to which will be the most effective.'
11
- While
I have not been provided with any detailed evidence that the restrictions
on
advertising will lead to a reduced or more appropriate uptake of vaping
(for example, among the smoking population as opposed to non-smokers),
it is
possible to draw a rational connection between those types of measures and that
objective. Reduced advertising of a product
may lead to reduced consumption of
that product, and the requirement for health messages on products can improve
public awareness
of the potential risks associated with their
use.
Is the impairment on the right greater than reasonably
necessary?
- It
is not clear that the approach taken in the Bill is the only response capable
of
answering concerns about the uptake of vaping. Other provisions such as
the notifications regime introduced in Part 4, and restrictions
on permitted
substances and nicotine levels in vaping products, demonstrate the availability
of more specific responses to the concerns
about emerging health risks. It has
not been shown that a complete prohibition on advertising is necessary to meet
the objective,
or that more limited measures (such as restrictions on
advertising times, locations or content) would not be
adequate.
Is the limit in due proportion to the importance of the
objective?
- The
remaining element of the section 5 inquiry calls for an assessment of whether
the
limits are in due proportion to the importance of the objective.
- In
my view, the objective of protecting public health is limited by the extent to
which
the evidence actually demonstrates a potential danger to public health.
As discussed above, the RIS supplied with the Bill indicates
that:
29.1 there is no current evidence of health risks connected
with vaping (and that
on the contrary vaping is significantly safer than smoking),
1° Canada (A-G) v JTI-McDonald Corp
[2007] 2 SCR 610 at [41 — 43]. 11 Canada (A-G) at [43].
29.2 the levels of nicotine used in vaping are unlikely to be harmful and
present a
low risk of addiction, and
29.3 there is no robust evidence supporting concerns of a 'gateway effect'
leading
young people who try vaping to subsequently take up smoking.
- Vaping
is associated with smoking and has unclear long-term health outcomes.
Given
the lack of research on this new product, some restrictive steps may be
justified in protecting against the potential for future health
risks to emerge.
However, if the evidence for harm associated with vaping is very limited, the
steps which can justifiably be taken
to protect against the risk of harm will
necessarily also be limited. At present, there appears to be no conclusive
evidence that
vaping is or will be harmful.
- The
Bill does seek to make some distinctions between the way in which its
restrictive
provisions apply to vaping, and specialist vape retailers, as
opposed to other tobacco products and more generic retailers. All retailers
are
permitted to display vaping products within their premises. Specialist vape
retailers are additionally permitted to recommend
and allow customers to trial
vaping devices within their premises. The plain packaging requirements, based on
regulations yet to
be developed, also appear intended to apply different
requirements to different types of product.
- However,
the Bill's prohibition on advertising (in addition to sponsorship
and
trademark usage) does not differentiate between vaping and traditional
tobacco use in this way. With some limited exceptions, the
Bill extends the
majority of the existing restrictions on the advertising of tobacco and applies
them to vaping products.
- While
some restrictions on advertising are likely justifiable in meeting the
above
objective, I do not consider that a blanket prohibition of the
advertising of vaping products is a proportionate response given the
lack of
evidence for their being harmful. In contrast, blanket bans on advertising and
significant restrictions on freedom of expression,
in the context of smoking,
can be justified due to the strong evidence of significant harm caused by
smoking, and the further evidence
that tobacco packaging is a highly effective
form of advertising for smoking products. In the absence of any strong evidence
of harm,
the support for such broad measures falls away.
- While
I acknowledge the public interest in remedying the current gap in the
regulation
of vaping, particularly given its high uptake among young persons,
the Bill of Rights Act requires such regulation to be measured
where protected
rights would be restricted.
- Accordingly,
given the broad nature of the advertising restrictions and in light of
the
limited evidence for harm associated with vaping, I do not
consider this limit on freedom of expression to be in due proportion to the
importance of the objective. I therefore conclude this limit on s 14 of
the Bill of Rights Act cannot be justified.
Section 19 of the
Bill of Rights Act (freedom from discrimination) — Age restriction
- I
have also considered whether the restrictions on the sale, and supply in a
public
place, of vaping products and heated tobacco devices to people under
the age of 18 years gives rise to a limit on the right to be
free from
discrimination (section 19 of the
Bill of Rights Act) on the basis
of age. One of the objectives of the Bill is to protect public health by
limiting the adoption of
vaping by non-smokers and, particularly, young
persons.
- Any
bright-line age restriction is necessarily arbitrary but provides a level of
certainty
and consistency in regulating behaviour where an individual
analysis is not practical. The age limit set by the Bill is one that has
been
generally adopted by society as appropriate for the purchase of other regulated
substances; including tobacco, herbal smoking
products and alcohol, and reflects
the greater vulnerability of young people to harm from such substances as well
as their decision-making
ability in using them appropriately. Such a precaution
is consistent with the objectives of the Bill, and in my view does not go
further than necessary in regulating a new product that is seeing high uptake
among young persons, is associated with tobacco and
carries uncertainty as to
its long-term health outcomes.
Conclusion
- I
have concluded the Bill appears to limit s14 of the Bill of Rights Act and
cannot be
justified under s 5 of that Act.
NZLII:
Copyright Policy
|
Disclaimers
|
Privacy Policy
|
Feedback
URL: http://www.nzlii.org/nz/other/NZBORARp/2020/6.html